Biopharma Industry Cheers US, EU's Joint AI Principles
A cross-Atlantic effort by regulators to develop a set of principles for using AI in drug development shows that U.S. and European agencies can find common ground to guide the life sciences industry in a critical area.
Dispatch From JPM: Fewer Health Deals Don't Dampen Mood
Despite an unusual dearth of big deal announcements, attorneys at the annual J.P. Morgan healthcare conference in San Francisco are still feeling positive about 2026.
Epic Systems Alleges Data Cos. Stole Records To Sell To Attys
Epic Systems, the nation's largest electronic health records company, told a California federal court on Tuesday that a health information network and a group of "bad actors" stole over 300,000 confidential patient records from health information exchange frameworks to illegally sell to third parties, including personal injury lawyers.
Biopharma Industry Cheers US, EU's Joint AI Principles
A cross-Atlantic effort by regulators to develop a set of principles for using AI in drug development shows that U.S. and European agencies can find common ground to guide the life sciences industry in a critical area.
Dispatch From JPM: Fewer Health Deals Don't Dampen Mood
Despite an unusual dearth of big deal announcements, attorneys at the annual J.P. Morgan healthcare conference in San Francisco are still feeling positive about 2026.
Epic Systems Alleges Data Cos. Stole Records To Sell To Attys
Epic Systems, the nation's largest electronic health records company, told a California federal court on Tuesday that a health information network and a group of "bad actors" stole over 300,000 confidential patient records from health information exchange frameworks to illegally sell to third parties, including personal injury lawyers.
Expert Analysis
Though much of the legislation introduced last year to expand state scrutiny of healthcare transactions did not pa... (more story)
Employer noncompete practices are facing intensified federal scrutiny and state reforms heading into 2026, with th... (more story)
The Centers for Medicare and Medicaid Services' recent proposed rule for the Medicare Advantage and Part D program... (more story)
Deals & Corporate Governance More
Investors in CorMedix Inc. have told a New Jersey federal judge that company directors have agreed to implement several corporate governance reforms to resolve a consolidated shareholder derivative lawsuit acc... (more story)
Law360 would like to congratulate the winners of its Practice Groups of the Year awards for 2025, which honor the attorney teams behind litigation wins and significant transaction work that resonated throughou... (more story)
Biotech company Lifecore Biomedical Inc. has reached a $3.8 million deal with its investors to end their claims the company had weak controls over its financial reporting, impairing its ability to remain compl... (more story)
A Delaware Chancery Court class action challenging the $110 million sale of medical device maker Bioness Inc. to Bioventus Inc. is reaching a resolution through an $8.9 million proposed settlement, capping yea... (more story)
New York Attorney General Letitia James on Thursday sued the former CEO of healthcare contractor Emergent BioSolutions Inc., alleging insider trading amid troubles manufacturing a COVID-19 vaccine, while signi... (more story)
Internal documents from Atrium Health Inc. show the company never intended to follow through on a partnership for a new Medicare Advantage health plan with a plan provider who spent tens of millions of dollars... (more story)
Digital Health & Technology More
Several coherent patterns emerged from 2025's data breach litigation activity, suggesting that judges have grown skilled at distinguishing between companies that were genuinely victimized by sophisticated crim... (more story)
An Illinois federal judge has released dental support organization Heartland Dental LLC and its contractor from a proposed class action accusing them of illegally using an artificial intelligence-powered note-... (more story)
Advertisements that ask South Dakota drivers two questions — "Pregnant? Don't want to be?" — have ignited an unusual First Amendment fight now underway in state and federal courts. Here's what to know about the issue.
A Kentucky federal judge on Monday granted preliminary approval of a nearly $5.3 million settlement between PharMerica Inc. and a proposed class of patients and employees who alleged the company failed to impl... (more story)
The Ninth Circuit on Friday reversed a decision tossing one of two classes in litigation accusing consulting firm Milliman of peddling inaccurate information by using a strategy known as "fuzzy" data matching ... (more story)
The Washington Supreme Court has taken up a group of parents' bid to revive their proposed class action accusing Seattle Children's Hospital of sharing their private data with Facebook parent company Meta by i... (more story)
Policy & Compliance More
A Connecticut mother and father have urged a state superior court judge not to rethink a $32 million bench trial verdict against Yale University and its affiliated Yale New Haven Hospital surrounding the death... (more story)
The New Jersey Office of the State Comptroller has demanded the owners of two Garden State nursing homes repay millions in Medicaid funds the office recently found they diverted to themselves while neglecting ... (more story)
This month, California became the nation's most populous state to mandate in vitro fertilization coverage for large group insurance plans. Health advocates say the new law is a gold standard for an inclusive d... (more story)
The U.S. Supreme Court on Tuesday ruled that a Delaware medical malpractice statute clashes with federal rules of procedure and is therefore unenforceable in federal court, saying the state law unfairly asks f... (more story)
The U.S. Supreme Court on Tuesday erased a Sixth Circuit decision allowing abortion-related conditions on family planning grants, a victory for Tennessee officials who accused the circuit of flouting the high ... (more story)
Former executives of Spero Therapeutics will pay over $187,000 to settle the U.S. Securities and Exchange Commission's claims they downplayed the likelihood that the U.S. Food and Drug Administration would rej... (more story)